State UT
Clinical Trials in Utah
Recruiting clinical trials with at least one study location in Utah. Data updated daily from ClinicalTrials.gov.
Top Conditions in Utah
NCT06395519 Phase 1, Phase 2
Recruiting
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Condition
Advanced or Metastatic Solid Tumors
Enrollment
120 pts
Location
United States
Sponsor
858 Therapeutics, Inc.
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
NCT06621251 Phase 2
Recruiting
Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosth...
Condition
Prosthetic Joint Infections of Hip
Enrollment
60 pts
Location
United States
Sponsor
Trellis Bioscience LLC
NCT05228886 N/A
Recruiting
The SINCERE Intervention to Address COVID-19 Health Disparities
Condition
COVID-19
Enrollment
1,500 pts
Location
United States
Sponsor
Andrea Wallace
NCT05230173 N/A
Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remi...
Condition
Ulcerative Colitis
Enrollment
250 pts
Location
United States
Sponsor
University of California, San
NCT04683653 Phase 1, Phase 2
Recruiting
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer
Condition
Endometrial Cancer
Enrollment
100 pts
Location
United States
Sponsor
University of Chicago
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
NCT05677451 Phase 3
Recruiting
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, ...
Condition
Chronic Spontaneous Urticaria
Enrollment
100 pts
Location
United States, Argentina, Canada
Sponsor
Novartis Pharmaceuticals
NCT07441694 Phase 1
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Condition
Myeloproliferative Neoplasms
Enrollment
218 pts
Location
United States, Australia, Belgium
Sponsor
Incyte Corporation
NCT06665256 Phase 2
Recruiting
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
Condition
Idiopathic Inflammatory Myopathies
Enrollment
123 pts
Location
United States, France, Germany
Sponsor
Novartis Pharmaceuticals
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06736418 Phase 1
Recruiting
Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC ...
Condition
Small-Cell Lung Cancer (SCLC)
Enrollment
65 pts
Location
United States
Sponsor
Abdera Therapeutics Inc.
NCT05213676 Phase 4
Recruiting
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
Condition
Congenital Diaphragmatic Hernia
Enrollment
600 pts
Location
United States
Sponsor
The University of Texas Health
NCT07089888 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Condition
Tophaceous Gout
Enrollment
250 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT05354141 Phase 3
Recruiting
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (...
Condition
Acute Respiratory Distress Syndrome
Enrollment
970 pts
Location
United States
Sponsor
Direct Biologics, LLC
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP
NCT06112990 Phase 3
Recruiting
Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Att...
Condition
Metastatic Prostate Cancer
Enrollment
200 pts
Location
United States
Sponsor
University of Utah
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
NCT05634369 Phase 1, Phase 2
Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK...
Condition
Pediatric Sarcoma, Refractory
Enrollment
50 pts
Location
United States
Sponsor
Nationwide Children's Hospital
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
NCT06801002 Phase 1
Recruiting
Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Soli...
Condition
Solid Tumor
Enrollment
25 pts
Location
United States
Sponsor
Jabez Bioscience, Inc
NCT03816345 Phase 1
Recruiting
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastati...
Condition
Autoimmune Disease
Enrollment
300 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT07006792 Phase 4
Recruiting
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Modera...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
NCT06866405 Phase 3
Recruiting
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vac...
Condition
RSV Infection
Enrollment
550 pts
Location
United States, Argentina, South Africa
Sponsor
Pfizer
NCT06212323 N/A
Recruiting
Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
Condition
Smoldering Multiple Myeloma
Enrollment
100 pts
Location
United States
Sponsor
University of Utah